Bleomycin A5 (Pingyangmycin) is an orally active bacterial metabolite[1][2].
Bleomycin A5 (Pingyangmycin) 能抑制肿瘤的生长[2]。
Bleomycin A5 (Pingyangmycin)（口服；18 日剂量 5 mg/kg）发生厌食、恶病质、皮肤溃疡、死亡，并观察到间质性肺炎、肾病和肾上腺皮质局灶性坏死[2]。
[1]. Yaowu Yang, et al. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. J Vasc Surg. 2011 Jan;53(1):150-5.
[2]. Lin Fu-Tian, et al. Antitumor activity and preclinical pharmacological study of pingyangmycin. Zhonghua Zhongliu Zazhi. Volume: 1. Issue: 3. Pages: 161-6. Journal; English Abstract; Article. 1979.